DNA screening for apolipoprotein (apo) B-100 mutations was performed in hyperlipidemic Chinese. The apo B-100 gene segment surrounding previously identified familial defective apo B-100 (FDB) mutations was amplified by PCR and subjected to single-strand conformation polymorphism (SSCP) analysis. One subject's aberrant SSCP band was cloned and sequenced to study the molecular lesions. A recurrent Arg CGG -to-Trp TGG mutation (R3500W) in the codon 3500 of the apo B-100 gene was identified. The C-to-T transition creates a NlaIII site and permits rapid restriction analysis of the mutation. A total of 373 hyperlipidemic patients and 309 controls were screened for R3500W. Nine unrelated subjects were shown to be heterozygous for the mutation, and no R3500W carriers were found in the control group (P ‫؍‬ 0.004). Six polymorphic markers, including five restriction fragment length polymorphisms and one hypervariable repeat region, were used for haplotype analysis on the mutant allele. In two families, the R3500W mutation could be unambiguously assigned to a unique haplotype XbaI؊/MaeI؉/MspI؉/EcoRI؉/ Eco57I؉/34 3HVR repeats; in the other seven unrelated heterozygotes, this finding was consistent when an unequivocal haplotype was deduced. The results suggest that all R3500W alleles are identical by descent in our population. The fact that the same mutant allele was identified in other Asians with FDB indicates a common Asian origin for the R3500W mutations.
The concentration of plasma cholesterol is mainly regulated by the LDL receptor pathway, in which circulating LDL is taken into the cells by receptor-mediated endocytosis (1) . Individuals with high LDL concentrations are often predisposed to premature coronary heart disease (CHD) 4 (2) . In principle, increased LDL concentrations that result from inefficient clearance of LDL particles by the receptor may derive either from defects in the receptor or from defects in the ligand. The former class of genetic disorder is familial hypercholesterolemia, an autosomal dominant disorder characterized by increased LDL concentrations, the frequent presence of tendon xanthomas, and premature CHD (3) . The later class, familial defective apolipoprotein (apo) B-100 (FDB), is also a dominantly inherited genetic disease. A CGG-to-CAG change in apo B-100 codon 3500 (Arg 3500 3 Gln) had been established as the cause of FDB (4, 5) . The change, which disrupts binding to the LDL receptor, increases the concentration of LDL bearing the altered apo B-100 relative to the unaffected LDL (4, 6) . Because the rate of removal of VLDL remnants by the LDL receptor was not affected (7) , such a defect was expected to lead to less severe hypercholesterolemia than in familial hypercholesterolemia (8 -12) . The incidence of FDB heterozygotes is 1:500 -1:700 in individuals of European and North American descent (8, 13, 14) .
Two other genetic forms of FDB has been described: a CGC-to-TGC change in codon 3531 (Arg 3531 3 Cys) (15, 16) and a CGG-to-TGG change in codon 3500 (Arg 3500 3 Trp) (17, 18) . The two mutations affect the function of apo B-100 by decreasing LDL receptor binding affinity (15, 17) . Haplotype analysis of the affected alleles, using markers within and/or flanking the apo B-100 gene, suggests that Arg 3500 3 Gln alleles are inherited from a common ancestor in several Western populations (16, 17, 19 -22) ; on the other hand, different haplotypes were found in one German and two Chinese subjects (23) (24) (25) . When chromosomal backgrounds were different, Arg 3531 3 Cys alleles were associated with different haplotypes (15) . That different haplotypes have been shown in two subjects of Asian and Scottish descent (17) also indicates that Arg 3500 3 Trp mutations arose independently in different ethnic backgrounds.
In the present study, 373 unrelated hyperlipidemic Chinese were screened by PCR and single-strand conformation polymorphism (SSCP) analysis to detect any changes in the apo B-100 gene segment surrounding codons 3500 and 3531. Nine heterozygotes with the Arg 3500 3 Trp mutation were identified. In addition, the apo B-100 haplotype at six polymorphic sites was examined to establish the origin of the founder carrying the mutation.
Materials and Methods subjects
Blood samples were collected after an overnight fast from 373 unrelated hyperlipidemic patients, ages 30 - 
dna preparation
Nuclei were separated after lysis of blood samples by centrifugation and digested in buffer containing 50 mg/L proteinase K, 10 mmol/L Tris, pH 7.8, 5 mmol/L EDTA, and 5 g/L sodium dodecyl sulfate. Genomic DNA was extracted using an automatic nucleic acid extractor (Genepure, 341 Nucleic Acid Purification Systems, Applied Biosystems). The DNA was quantified as described (26) and diluted to a concentration of 100 mg/L.
pcr amplification
Regions of the apo B-100 gene were amplified by PCR. Genomic DNA (250 -500 ng) was used for a 50-L PCR reaction containing 10 mmol/L Tris, pH 8.3, 50 mmol/L KCl, 1 mL/L Triton X-100, 0.2 mmol/L deoxynucleotide triphosphates, 0.4 mol/L of each primer, and 1 U Taq DNA polymerase (Promega). Specific PCR conditions are listed in Table 1 . PCR analyses were performed in an automated thermal cycler (1605 Air Thermal Cycler, Idaho).
nonisotopic sscp analysis
The primer pair apoB-5Ј and apoB-3Ј (Table 1 ) flanks 345 bp of the apo B-100 sequence from nucleotide 10 551 to nucleotide 10 895 (27) . The PCR-amplified products were restricted into 141-and 204-bp fragments by EcoRI to optimize SSCP fragment size. Ten microliters of the restricted products were mixed with an equal volume of formamide buffer (950 mL/L formamide, 10 mmol/L EDTA, 1 g/L bromphenol blue, and 1 g/L xylene cyanol). The mixture was denatured for 10 min at 95°C and then cooled rapidly on ice and held for 5-10 min. For each sample, 15 L were loaded onto nondenaturing polyacrylamide gels [0.5ϫ Hydrolink MDE (J.T. Baker) in 0.6ϫ Tris-borate-EDTA] and run at 4°C for 2.5 h at 250 V (Novex Xcell II). Gels were stained with ethidium bromide (0.5 mg/L) for 20 min, destained for 15 min, and photographed under ultraviolet light. The nucleotide positions were referred to Ludwig et al. (27) . b HVR-5Ј, ggcacagcaaaacctctagaacacatagtg; HVR-3Ј, ccttctcacttggcaaatagaattcctgag.
dna sequencing
Aberrant SSCP products from individual 95-020 were gel purified, subcloned into pGEM-T (Promega), and sequenced by the dideoxynucleotide chain termination method (28). The sequencing products were then separated on a 6% polyacrylamide gel containing 7 mol/L urea, and the separation was monitored on-line with an automated laser fluorescent DNA Sequencer (A.L.F.; Pharmacia LKB Biotechnology AB). Four to six independent clones were sequenced.
restriction analysis of the r3500w mutation
The R3500W mutation is caused by a C-to-T transition at nucleotide 10 707 of the apo B-100 gene. The mutation creates a NlaIII restriction site (CATG). The 345-bp PCRamplified products were digested with NlaIII and separated on a 2.0% agarose gel.
haplotype markers
Six markers were analyzed to establish haplotypes at the apo B-100 locus. These markers were as follows: polymorphic XbaI (27) , MaeI (29) , and MspI (30) 
Results identification of the r3500w mutation
A region of 345 bp in exon 26 of the apo B-100 gene was amplified and screened for mutations. A photo of DNA screening by SSCP analysis in a Hydrolink MDE mini gel is shown in Fig. 1 . Of the hyperlipidemic patients examined, most showed two intensely stained bands (Fig. 1,  lanes 3 and 5, arrows a and c) , representing the major conformers of the two single strands from an EcoRIrestricted 204-bp fragment. Conversely, subjects with aberrant SSCP bands were found (Fig. 1, lanes 1, 2, and 4 ; arrow b). Sequencing of the cloned aberrant band from one subject revealed a C-to-T transition at nucleotide 10 707, producing the substitution of glutamine for tryptophan in the codon 3500 of the apo B-100 gene (R3500W; data not shown). The recurrent R3500W mutation (17, 18) creates a new NlaIII site on the PCR products so that, on digestion in heterozygotes, 189-and 156-bp fragments appeared in addition to the wild-type 345-bp fragment (Fig. 2, lanes 1-3) . Among 373 hyperlipidemic patients examined, 9 unrelated subjects heterozygous for R3500W mutation were identified. No R3500W mutation was found in 309 individuals in the control group (data not shown). When examined by the Fisher Exact test, a significant association was found between R3500W mutation and hyperlipidemia (P ϭ 0.004).
A total of 13 family members of R3500W heterozygotes 95-020 and 95-026 gave consent to be screened for the mutation. In the 95-020 family, the proband (II-2) inherited the mutation from his father (I-1). Three of his siblings (II-4, II-5, and II-7) also carry the mutation (Fig. 3,  upper panel) . In the 95-026 family, one of the sons (II-4) inherited the mutation from the proband (I-1; Fig. 3 , lower panel).
haplotype analysis on the mutant allele
The genotypes at six polymorphic loci were examined. The results of genotyping of the 95-020 and 95-026 fami- The 345-bp PCR-amplified products were digested to completion with NlaIII and resolved in a 2.0% agarose gel. In the presence of the mutation at codon 3500, the 345-bp fragment is cut into two fragments of 189 and 156 bp (lanes 1-3) . Lane M (HinfI digest of pGEM4 DNA) contains size markers.
Clinical Chemistry 44, No. 8, 1998 lies are shown in Table 2 . A total of 30 chromosomes yielded six independent haplotypes, including a new one generated from unequal crossing-over or replication error (haplotype E). R3500W alleles were associated with haplotype B: XbaIϪ/MaeIϩ/MspIϩ/EcoRIϩ/Eco57Iϩ/34 3ЈHVR repeats in the two families.
Seven other subjects (95-040, 95-129, A46, D10, D47, D53, and D149), heterozygous for the same mutation, were genotyped. The lack of DNA from family members precluded unambiguous resolution of each of their haplotypes. When an unequivocal haplotype was deduced, one of the two alleles could be haplotype B (Table 3 ). The results suggest that their mutant alleles are identical to those of subjects 95-020 and 95-026. Thus, all R3500W alleles are likely identical by descent in our population.
lipoprotein concentrations
The clinical and biochemical features of the nine Arg 3500 3 Trp heterozygotes and 13 members of 95-020 and 95-026 families are shown in Table 4 . The cholesterol concentrations of the eight index cases (95-020, 95-026, 95-040, 95-129, D10, D47, D53, and D149) were moderately increased (7.16 -8.37 mmol/L), similar to those Ͼ40 years old reported for R3500W heterozygotes (6.6 -8.6 mmol/L) (17, 18) . On the other hand, the index case A46 and five identified heterozygous relatives of probands 95-020 and 95-026 had serum cholesterol concentrations close to or only slightly Ͼ5.17 mmol/L (5.04 -5.92 mmol/L).
Discussion
A total of 373 unrelated hyperlipidemic individuals were screened for the presence of apo B-100 mutations. Nine Arg 3500 -to-Trp index cases were found, seven classified as having type IIa and two as having type IIb hyperlipidemia (Table 4) . One type IIa index case (A46) had a history of CHD. Of these, together with the four cases described, one was of Scottish descent and the others were of Asian descent (17, 18) , a total of 13 index cases of this new mutation was reported. The recurrent arginine-to-tryptophan substitution is dysfunctional in that it allows only poor growth of a LDL-cholesterol-dependent U937 cell line (17) . From the sample of patients examined here, the mutation is estimated to occur at a frequency of ϳ1:42 in hyperlipidemic Chinese. The mutation appears to be a significant factor contributing to moderate hypercholesterolemia in Chinese (P ϭ 0.004).
R3500W alleles reported were associated with different haplotypes of different chromosomal backgrounds: haplotype XbaIϩ/MspIϪ/EcoRIϩ in a Scottish descendant and haplotype XbaIϪ/MspIϩ/EcoRIϩ in three Asians (17, 18) . In addition, 35 3ЈHVR repeats (according to the nomenclature by Boerwinkle et al. (36) ) were found associated with the haplotypes of two Asians (a Chinese and a Malay) (18) . Compared with our studies, the haplotype associated with R3500W alleles in Chinese, XbaIϪ/MspIϩ/EcoRIϩ/34 3ЈHVR repeats (according to the nomenclature by Ludwig et al. (37) ; Table 3 ) concurs with that reported previously for other Asians with FDB Family 95-026 95-026 ( 17, 18) . The results suggest that Arg 3500 3 Trp alleles are inherited from a common ancestor in Asian populations. In Caucasians, different haplotypes are associated with the R3500W allele (XbaIϩ/MspIϪ/EcoRIϩ) (17) and the majority of R3500Q alleles (XbaIϪ/MspIϩ/EcoRIϪ) (16, 17, 19 -22) , thus suggesting an independent origin of the two mutations. The R3500Q alleles in Chinese were reported to occur on two different haplotypes: XbaIϪ/ MspIϩ/EcoRIϩ/30 3ЈHVR repeats (23) and XbaIϩ/ MspIϩ/EcoRIϩ/44 3ЈHVR repeats (25) . In our studies, the haplotype associated with R3500W alleles in Chinese, XbaIϪ/MspIϩ/EcoRIϩ/34 3ЈHVR repeats, was different from those with R3500Q alleles. Thus, independent origins of the two mutations in Chinese are also suggested.
In general, haplotype markers are ancient and predate human racial divergence. Because R3500W and R3500Q mutations occurred on different haplotypes in both Caucasians and Chinese, relatively recent independent mutations of the CG dinucleotide to TG or CA are therefore indicated. By considering the geographical distribution of the R3500Q mutation in relation to what is known about early human migrations, an origin for the ancestral CGto-CA mutation in continental Western Europe was suggested (38) . When the amount of recombination between the apo B-100 gene and markers on chromosome 2 in 34 R3500Q probands in which the mutation was on the same haplotype was estimated, the ancestral CG-to-CA mutation was estimated to occur ϳ6000 -7000 years ago (38) . The hypermutable CG dinucleotide is frequently associated with point mutations of various genes (39) .
The R3500W mutation is the result of a C-to-T transition at nucleotide 10 707, a base pair adjacent to the previously described R3500Q mutation, a G-to-A transition at nucleotide 10 708. The analogous substitution of the Arg residue with Gln or Trp was also found in codon 441 of the sterol 27-hydroxylase gene (40) . The substitution of arginine by tryptophan or glutamine at apo B-100 codon 3500 affects its ability to bind to the LDL receptor (4, 6, 17) . That two independent mutations are associated with the same phenotype suggests that the loss of the arginine residue rather than the appearance of glutamime or tryptophan is causing the impaired binding.
The 3ЈHVR locus in II-3 had 34/38 repeats; on the other hand, 34/36 repeats were found in her parents ( Table 2 ). The sample identity was verified by examining other polymorphic loci in the 5Ј region of the apo B-100 gene (data not shown). The discrepancy observed in 3ЈHVR repeats is likely to be attributed to slippage during DNA replication with the HVR itself. On average, a 5% gain or loss in repeat number was observed in studies of spontaneous change to new-length alleles within pedigrees for a variety of hypervariable loci (41) . The postulated change from 36 (in haplotype A) to 38 (in haplotype E) HVR repeats is consistent with this view.
In conclusion, apo B-100 R3500W heterozygotes were identified in hyperlipidemic Chinese subjects. The Arg 3500 3 Trp alleles in Asians appear to have originated in a common ancestor many years ago. In view of the potential association of the mutation with CHD, screening for it is therefore of value in determining the potential risk of premature atherosclerosis. Clinical Chemistry 44, No. 8, 1998 
